Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial (Q34375398)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial |
scientific article |
Statements
1 reference
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial (English)
1 reference
Jay Horton
1 reference
Kevin Fitzgerald
1 reference
Maria Frank-Kamenetsky
1 reference
Svetlana Shulga-Morskaya
1 reference
Abigail Liebow
1 reference
Brian R Bettencourt
1 reference
Jessica E Sutherland
1 reference
Renta M Hutabarat
1 reference
Valerie A Clausen
1 reference
Verena Karsten
1 reference
Jeffrey Cehelsky
1 reference
Saraswathy V Nochur
1 reference
Victor Kotelianski
1 reference
Timothy Mant
1 reference
Joseph Chiesa
1 reference
James Ritter
1 reference
Malathy Munisamy
1 reference
Akshay K Vaishnaw
1 reference
Jared A Gollob
1 reference
Amy Simon
1 reference
3 October 2013
1 reference
Identifiers
1 reference